Contact us
Pneumococcus vaccine development support
SSI Diagnostica Group’s involvement in vaccine development began over 40 years ago—then as Statens Serum Institut—by supplying antisera for quality control to a global vaccine manufacturer during the development of a pneumococcal vaccine. Today, SSI Diagnostica Group continues to provide leading vaccine developers including GSK with high-quality products and scientific expertise across multiple disease areas.
Currently available pneumococcal vaccines
Currently licensed vaccines for Pneumococcus (also known as Streptococcus pneumoniae) include conjugate (PCV15, PCV20, and PCV21) and polysaccharide (PPSV23) vaccines. Public-health recommendations vary by age, risk factors, and region1.
Pneumococcus products and disease expertise across the vaccine development lifecycle
Our portfolio is structured to meet the evolving needs of vaccine developers from research & development all the way to post-market surveillance.
*to be used in in-house assays for antibody immune response assays
Please note
Product availability may vary by country. Some products listed in the table might not be registered or available in all markets. For detailed information on distribution and registration status in your region, please contact SSI Diagnostica Group or your local representative.
How we can support your Pneumococcus vaccine development
Research & development
- Supporting serotype identification and discovery
- Supporting with consistent QC design
- Providing raw materials as reference strains and antigens
Preclinical trials
- Raw material and support for in-house assay development
Clinical trials
- IVD tests for pre-screening of study participants
- Raw material and support for in-house assays
Production
- Scalable supply of validated reagents
Post market surveillance
- Ongoing support for surveillance and refinement
Customization and contract manufacturing services:
- Available across all development stages
SSI Diagnostica Group as your vaccine development lifecycle partner
- Trusted by leading vaccine manufacturers for 40+ years
- High quality IVD products (IVDD / IVDR)
- Stable supply by 100% in-house production
- Global distribution (130+ countries)
- Compliant with manufacturing, regulatory and environmental standards / requirements (ISO 13485, ISO 14001, 21 CFR 820)
Discover other vaccine development areas
Ready to accelerate your vaccine project?
Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat. In id cursus mi pretium tellus duis convallis. Tempus leo eu aenean sed diam urna tempor.
Pulvinar vivamus fringilla lacus nec metus bibendum egestas. Iaculis massa nisl.